Popular Posts

Translate

Showing posts with label hepatitis C. Show all posts
Showing posts with label hepatitis C. Show all posts

Hepatitis C-What are the symptoms of hepatitis C infection?

About 75% of people have no symptoms when they first acquire HCV infection. The remaining 25% may complain of fatigue, loss of appetite, muscle aches or fever. Yellowing of the skin or eyes (jaundice) is rare at this early stage of infection.
Over time, the liver in people with chronic infection may begin to experience the effects of the persistent inflammation caused by the immune reaction to the virus.
 Blood tests may show elevated levels of liver enzymes, a sign of liver damage, which is often the first suggestion that the infection may be present. Patients may become easily fatigued or complain of nonspecific symptoms.
As cirrhosis develops, symptoms increase and may include :
1.weakness,
2.loss of appetite,
3.weight loss,
4.breast enlargement in men,
5.a rash on the palms,
6.difficulty with the clotting of blood, and
7.spider-like blood vessels on the skin.
In patients with advanced cirrhosis, the liver begins to fail. This is a life-threatening problem. Confusion and even coma(encephalopathy) may result from the inability of the liver to process certain toxic substances.
Increased pressure in the blood vessels of the liver (portal hypertension) may cause fluid to build up in the abdominal cavity (ascites) and result in engorged veins in theswallowing tube (esophageal varices) that tear easily and can bleed suddenly and massively. Portal hypertension also can cause kidney failure or an enlarged spleenresulting in a decrease of blood cells and the development of anemia, increased risk of infection and bleeding.
In advanced cirrhosis, liver failure causes decreased production of clotting factors. Patients with advanced cirrhosis often develop jaundice because the damaged liver is unable to eliminate a yellow compound, called bilirubin that is formed from the hemoglobin of old red blood cells.

tags:the liver (portal hypertension) ,Hepatitis C, hepatitis C infection? anemia, risk of infection, and bleeding,yellow compound,hepatitis C,the liver virus

Testing for Hepatitis C


Testing for Hepatitis C:Recent clinical trials indicate that today, a combination of pegylated interferon (PEG-IFN) and Ribavirin is the treatment of choice for patients with chronic hepatitis C.However, the usefulness of HCV Core Ag testing for monitoring virologic response during and after this new treatment regimen remains to be confirmed.
To study the correlation between total Hepatitis C virus (HCV) Core antigen (Ag) and HCV-RNA, and to assess the proficiency of HCV Core Ag testing in monitoring and predicting virologic response during and after pegylated interferon (PEG-IFN) and ribavirin combination therapy.
The determination of total HCV Core Ag levels in serum, constitutes an accurate and reliable alternative to HCV-RNA for monitoring and predicting treatment outcome in patients receiving PEG-IFN/Ribavirin combination therapy.
Baseline viral load levels and infecting genotype help to predict the outcome of therapy and influence the choice of the therapeutic regimen. In the present study, we studied in a clinical setting the correlation between total HCV Core antigen (Ag) and HCV-RNA, and assessed the proficiency of HCV Core Ag testing to monitor and predict virologic response during and after PEG-IFN and ribavirin combination therapy.

Hepatitis C - Symptoms-Patient Comments:


Hepatitis C - Symptoms-Patient Comments:

- The only thing that seems consistent is that I'm always exhausted. There is no such thing as enough sleep for me. I require cup after cup of coffee in the daytime and several hours of sleep at night, and I still feel tired. Other than that, all my symptoms seem so random. I have occasional aches and pains. My stomach hurts a lot, and I just plain don't feel good a lot of them time. I don't know how long I have had hepatitis C.
- My family and friends mean the world to me and they all are very supportive. I just don't know if I have the strength or faith to fight this one. I'm tired all the time, sick all the time and just feel achy in my muscles. Is there a support group out there that I can contact? Others that are going through the same things as me?I'm really scared!!! Just found out 3 days ago that I have Hep C. I don't know what to do or who to turn to. I'm supposed to contact my dr. to start treatment but at this point I just feel like I want to curl
-  I thought I was going to die, four two months the emergency room still could not find out what was wrong with me. Test after test was given to me but no one knew what was wrong with me. I have no tatoos, do not use drugs no history of sexual activity other than my husband. Finally an ER doctor asked me if he could check one more option so I agreed he said the test was for Hep C since he noticed I had to be given blood 4 years prior. That's when I was told I had Hep C. I visited with a hep doctor and he told me that the level readings were so high he didn't even want a liver biopsy because my liver was so bad. The doctor put me on the pegasist\interfuron program. I stayed in constant pain, I was so tired I had to clean my house slowly and in shifts it took me almost all day to get my housework done. My pain would not stop and was constant my abdomen, liver area back and the constant fight for my breath I really thought I was going to die ...
- that lead to a blood test which lead to hep test and bam I had Hep-C. I don't know how I contracted it and that is a private matter but now I have to figure out how to live with it. I have an option for the meds which is called infer ion something like that but I didn't do that as of yet. I take all sorts of medicine like methadone, Ritalin, lortab and prilosic. Now I have to take this for that and that for this so I am skeptical on what to take because I have good days and bad ones......

New drugs against hepatitis C

 Currently, people usually get hepatitis C by sharing needles for injection drug use. An HCV-infected woman can pass the infection to her baby during birth. It is also possible to get hepatitis C from an infected person through sexual contact, an accidental needlestick with a contaminated needle, or improperly sterilized medical, acupuncture, piercing, or tattooing equipment.

Hepatitis C can be treated and cured. Almost everyone living with HCV can now be cured with a one-pill-a-day regimen in eight-to-twelve weeks. These new medications are generally well-tolerated. In order to access HCV treatment, it is necessary to see your doctor to discuss treatment options. Access to treatment continues to improve as new medication regimens are made available by private health insurers and public health programs.

Tags:hepatitis C,injection drug,HCV,

Hepatitis C

 Hepatitis C is a viral infection that causes inflammation and damage to the liver. Inflammation is the swelling that occurs when body tissues are injured or infected. Organs can be damaged by inflammation.

Although there is no vaccine for hepatitis C, you can take precautions to protect yourself. If you have hepatitis C, consult your doctor about treatment options. Most cases of hepatitis C can be cured with medications.Hepatitis C infection can be acute or chronic.

Viruses NIH external link infiltrate healthy cells in your body. Many viruses cause infections that can be passed from one person to the next. Contact with the blood of an infected person spreads the hepatitis C virus.

Although there is no vaccine for hepatitis C, you can take precautions to protect yourself. If you have hepatitis C, consult your doctor about treatment options. Most cases of hepatitis C can be cured with medications.


Tags:hepatitis C,viruses,infection,

My diagnosed hepatitis C treatment

Diagnosed hepatitis C  treatment

Diagnosed 1992
Pegintron treatment 2004 unsucessful
Genotype 1b
FibroScan 10 (F2)
Start Viekira 10.17.2015
Viekira is used to treat chronic hepatitis C in adults. It is sometimes given in combination with another antiviral medicine called ribavirin.

AST 49 ALT 76
VL 440k
10.31.2015/Week 2 Labs : AST 14/ALT 17
No VL done
10.14.2015/Week 4 labs : AST 14/ALT 14
VL UNDETECTED!!!
12.11.2015/Week 8 Labs : AST 12/ALT 13
No VL done
01.05.2016/EOT labs : AST 15/ALT 13
VL UNDETECTED!!!

12 WEEK SRV:UN-BLOODY DETECTABLE !!!!!!!!

24 WEEK SVR:UNDETECTABLE!!!! 

He did not come back,yeeees!

Viekira is an antiviral medicine containing a combination of dasabuvir, ombitasvir, paritaprevir, and ritonavir. Dasabuvir, ombitasvir, paritaprevir, and ritonavir are antiviral medicines that prevent the hepatitis C virus (HCV) from multiplying in your body.



tags:diagnosed.treatment,hepatitis C,viekira,

HEPATITIS C VIRUS

Hepatitis C is a flavivirus (of which yellow fever is the prototype) that causes non-A, non-B hepatitis. Flaviviruses (figure 5) are icosahedral, positive strand RNA viruses and gain an envelope from their host cell. The virus particle is about 30 to 60nm across. The genome of 9,600 bases codes for ten proteins. In many ways, the flaviviruses are similar to picornaviruses with the prominent exception that they are enveloped. The viral RNA does not have a 5’ cap or 3’ poly A tract. Translation of the viral RNA is mediated by the internal ribosome entry site (IRES).

There is one protein product from one open reading frame. The hepatitis C virus polyprotein is cleaved by both a virally-encoded protease activity and a cellular protease. The nascent protein contains a signal sequence that results in the translating ribosome attaching to the cytoplasmic surface of the endoplasmic reticulum. The envelope protein (E) thus crosses and embeds in the membrane and the signal sequence is removed by a cellular signal protease. This results in the remainder of the protein, the core protein, becoming cytoplasmic. It is cut by two viral proteases. The C-terminal domain of NS2 is a cysteine protease and cleaves at the NS2/NS3 junction. Another protease (NS3/4A serine protease) cleaves the remaining junctions.
Thus, the core protein is cut into NS1, NS2, NS3 and NS4 proteins. NS2 and NS4 are then cut again (to give NS2a, NS2b, NS4a and NS4b)
HCV binds to either the CD81 antigen or low density lipoprotein (LDL) receptor on hepatocytes via its E2 glycoprotein. There is also some evidence that it may bind to glycosaminoglycans.

tags:hepatitis C,virus hepatitis C,The hepatitis C virus polyprotein ,HCV,liver,

Coffee and hepatitis C

Coffee and hepatitis C....This study included 766 participants enrolled in the Hepatitis C Antiviral Long-Term Treatment against CirrhosisAmong chronic hepatitis C patients with advanced liver fibrosis or cirrhosis who did not respond to interferon-based therapy, those who drank 3 or more cups of coffee per day had a 53% lower risk of liver disease progression than non-coffee-drinkers, according to a study that will appear in the November 2009 issue of Hepatology.
Outcome rates declined with increasing coffee consumption, from 11.1 per 100 person-years [PY] for patients who drank none, to 12.1 per 100 PY for those who drank less than 1 cup a day, to 8.2 per 100 PY for those who drank between 1 to fewer than 3 cups a day, to 6.3 per 100 PY for patients who drank 3 or more cups a day.


Results from study suggest that patients with high coffee intake had a lower risk of disease progression.....

tags:hepoatitis C,

Liver and Hepatitis A,B,C ,D,E.....?



Hepatitis:

Hepatitis D is caused by the virus "HDV"You can only get hepatitis D if you are already infected with hepatitis B.


You get hepatitis E by drinking water infected with the virus.This type of hepatitis doesn't occur often in the United States.


Hepatitis A is caused by eating food and drinking water infected with a virus called "HAV".


Hepatitis B is spread through contact with an infected person's blood, semen or other body fluid.

Hepatitis C is spread the same way as hepatitis B, through contact with an infected person's blood, semen or other body fluid.

Most people who get hepatitis A are never even aware of it because they never show any symptoms.

tags:hepatitis ABCDEFG,

Chronic Hepatitis C oral tablet

Chronic Hepatitis C:Our group of value specialists who keep up the nature of the secured prescriptions guarantee each drug is sheltered to devour. Our bundling specialists utilize just therapeutic review bundling material to pack these prescriptions previously providing to the customers.

 Supported by a huge appropriation arrange, we have possessed the capacity to convey customers’ requests inside stipulated time allotment at their endSofosbuvir 400 mg,+Velpatasvir 100 mg. Introducing first global generic oral tablet for pan-genotypic Chronic Hepatitis C Patient named “SOFOSVEL”.
This is a fixed dose combination drug and it is used in the treatment of Chronic Hepatitis C (HCV). It has a very high cure rates for all genotypes of HCL infection (HCL genotypes 1, 2,3,4,5 or 6). It contains sofosbuvir and velpatasvir.

Sovosfel-Sofosbuvir 400 mg,+Velpatasvir 100 mg. Introducing first global generic oral tablet for pan-genotypic Chronic Hepatitis C Patient named “SOFOSVEL”.

You can find Sofosvel price suppliers buy online India.

Tags:Chronic Hepatitis C,India,sofosvel,oral tablet ,

Research


Antibody to hepatitis C virus and liver disease in volunteer blood donors

Hepatitis C virus (HCV) is the major cause of transfusion-associated hepatitis that is neither hepatitis A nor hepatitis B, and one screening test for the antibody to the virus (anti-HCV) is called the ELISA (enzyme-linked immunosorbent assay). ž
However, this test can give false-positive results, suggesting the presence of disease when, in fact, it does not exist. A more specific test is the recombinant immunoblotting assay or RIBA, which determines whether antiviral antibodies present are specifically directed against HCV. To learn more about the specificity of anti-HCV antibodies among blood donors, a study was carried out of a group of 50 donors found to be positive for HCV using ELISA. The subjects' blood was analyzed using the RIBA test. Results showed that 13 of the donors (26 percent) tested positive on RIBA analyses and 6 had indeterminate results with elevated levels of a liver enzyme that indicates disease. 

Twenty patients had negative RIBA results and normal results on tests of liver enzymes. The 19 patients with positive or indeterminate results underwent liver biopsies to determine whether liver disease was present. 

The 6 patients whose RIBA patterns were indeterminate had no signs of active hepatitis on biopsy. Of the 13 with positive RIBA tests, 8 were found to have chronic active hepatitis; in 2 cases, signs of cirrhosis (a condition in which fibrous tissue replaces liver tissue) were noted. 

Blood donors who test HCV-positive with ELISA and then with RIBA should be referred for further medical follow-up, as they could have active liver disease. No statement can be made about those who are positive for HCV on ELISA and then negative on RIBA, as none of them underwent liver biopsy. The anti-HCV RIBA is a useful aid for identifying blood donors with underlying chronic liver disease.

tags:liver,patients,RIBA,hepatitis C,

The liver and hepatitis C


The liver is one of the most important organs in the human body. Our largest organ, the liver is located in a central position of the abdomen, and is intimately involved in almost every aspect of the body's processes.
Because of its central role, liver disease strikes at the very heart of the body's functions and processes - and can be extremely life-threatening. You cannot live without a liver
While the liver serves a variety of functions, the most crucial is its role in the body's metabolism. There is no organ that is more important to healthy metabolism than the liver - in many ways, it is as central to metabolism as the heart is to the circulation of blood. The liver plays a critical role in four key areas of metabolism: fuel management, nitrogen excretion, the regulation water distribution between the blood and tissues, and the detoxification of foreign substances. Because of the crucial importance of healthly metabolism to overall health, diseases of the liver, such as hepatitis C, can be devastating, leading to fatigue, malaise, and even to death

The liver is subject to a variety of other disorders and diseases. Abscesses can be caused by acute appendicitis; those occurring in the bile ducts may result from gallstones or may follow surgery. The parasite that causes amebic dysentery in the tropics can produce liver abscesses as well. Various other parasites prevalent in different parts of the world also infect the liver. 
Cancers of the liver are common, most of them secondary tumours originating elsewhere in the body.
Glycogen-storage diseases, a group of hereditary disorders, generate a buildup of glycogen in the liver and an insufficient supply of glucose in the blood. Certain drugs may damage the liver, producing jaundice.



tags:The liver is subject to a variety,diseases of the liver, such as hepatitis C,

hepatitis A,B,C




Hepatitis C, like other forms of hepatitis, causes inflammation
 of the liver. The hepatitis C virus is transferred primarily
 through blood, and is more persistent than hepatitis A or B.
 Worldwide, estimates suggest 170 million people are
 chronically infected with hepatitis C, with 3 to 4 million 
people newly infected each year.2

How hepatitis C is spread

High-risk groups are the same in many societies and cultures. 
They include injecting drug users, people who receive transfusions 
of unscreened blood, haemophiliacs, dialysis patients and 
people who have unprotected sex with multiple sex partners.
The hepatitis C virus (HCV) can be spread in the following ways:
by sharing drug-injecting equipment (needles, heating spoons, etc). This is the primary transmission route for HCV and HIV outside 
sub-Saharan Africa.
by using non-sterilised equipment for tattooing, acupuncture or
 body piercing. This can be a problem in countries where 
tattooing or scarification is a traditional ritual practice.
through exposure to blood during unprotected sex with an
 infected person. Blood may be present because of genital sores, cuts or menstruation. Sexual transmission is an uncommon way
 of becoming infected with hepatitis C.
rarely, from an infected mother to her baby during childbirth. 
The risk may be greater if the mother is also infected with HIV.
through blood transfusion. In many developing countries blood is 
not screened (tested) for the hepatitis C virus. All blood
 for transfusion in the UK and USA is tested.
by sharing equipment used to snort cocaine. Usually this is 
a rolled banknote, which can become contaminated with blood 
from a person’s nose.
Hepatitis C cannot be passed on by hugging, sneezing, 
coughing, sharing food or water, sharing cutlery, or casual contact.

Signs and symptoms of hepatitis C

Many people do not experience any symptoms when they 
become infected with hepatitis C. Symptoms may emerge later, taking anywhere between 15 and 150 days to develop.
 Occasionally a person will not develop any symptoms
 and their immune system will successfully clear the virus
 without their knowledge. An infected person without symptoms 
can still act as a carrier and pass the virus on to others.
Symptoms may include:
a short, mild, flu-like illness.
nausea and vomiting.
diarrhoea.
loss of appetite.
weight loss.
jaundice (yellow skin and whites of eyes, darker yellow urine 
and pale faeces).
itchy skin.
About 20% of individuals who become infected with HCV will 
clear the virus from their body within 6 months, though this
 does not mean they are immune from future infection with HCV.
The other 80% of people will develop chronic hepatitis C
 infection, during which the virus may cause mild symptoms
 or no symptoms at all. These people will however carry
 the hepatitis C virus for the rest of their lives and will 
remain infectious to others.
If a person lives with hepatitis C infection for a number of years
 then they may develop the following complications:
chronic hepatitis.
liver cirrhosis.
liver cancer.
If symptoms become severe then a person with hepatitis C may
 be admitted to hospital for monitoring and treatment.

Where to go for help

If you have any symptoms or you are worried you may have 
been infected with hepatitis C, you should discuss your worries
 with a doctor. They may be able to run tests themselves, 
or else will refer you to someone who can.
Some countries have specific sexual health clinics that can help
 you directly. Check our help and advice page or your 
local telephone directory to see if you have a clinic near you.

The tests for hepatitis C

Tests for the hepatitis C virus have only been available since 1989.
 A doctor can diagnose hepatitis C by carrying out blood tests
 that detect HCV antibodies in the blood.

What does a positive test result mean?

The first test searches for HCV antibodies in the patient’s blood.
 A positive result shows that the person has been exposed to 
the hepatitis C virus and their immune system has responded
 by producing antibodies.
This may mean that the patient is a carrier of the hepatitis C virus. Alternatively, the patient may have recently cleared an
 HCV infection and still have antibodies in their blood. Further 
tests will be conducted to discern whether the patient has a 
current infection.
A specialist will carry out a blood test that looks for the 
genetic material of the hepatitis C virus itself instead of 
the antibodies. This test will identify whether the virus is
 still present.
If the patient has successfully cleared the virus, this does not 
mean they are immune to reinfection.

What does a negative test result mean?

A negative result generally means the patient has never 
been infected with HCV. However, as the tests rely on the 
detection of antibodies to HCV, and the antibodies can take some months to develop, the doctor may advise the patient to take
 a repeat test if they believe they may have been recently exposed to the virus.

Follow-up

If a patient has been diagnosed with hepatitis C infection, they 
will be advised to have regular blood tests and physical check-ups.
The infected person should limit the amount of alcohol they drink
 as alcohol puts strain on the liver. The doctor may also 
advise avoiding fatty foods and following a low-salt diet.

Prevention

Currently, there is no vaccine for hepatitis C, but research is in progress. Like HIV, HCV can mutate easily, which makes vaccine development complicated. As no vaccine exists, all measures should be taken to prevent HCV transmission.
Injecting drug users should never share any needles, syringes or mixing spoons, as blood can be transferred between users.
Infection through penetrative sex does occur, although it is not common. If a person is infected with HCV, it is advisable for them to use a condom for penetrative sex to ensure that they do not pass on the virus to their partners through any open genital cuts or sores.
People should avoid sharing toothbrushes, shaving equipment (especially razors), or anything else that may be contaminated with infected blood.
The doctor will advise the patient of any precautions necessary to avoid infecting others with the virus.

Treatment

To determine the extent to which the liver has been affected by hepatitis C, two more tests will be carried out.
The first is a liver function test (LFT) which measures substances (specific proteins and enzymes) in the patient’s blood, showing how effectively the liver is working.
The second is a liver biopsy. A fine hollow needle is passed through the skin into the liver and a small sample is taken. The sample is then examined under a microscope to gauge the amount of liver damage (inflammation, scarring and cirrhosis).
Treatment for hepatitis C has improved in recent years, but at maximum efficacy it is still only successful at clearing HCV in around 30%-50% of patients.
Treatment combines the antiviral drugs interferon and ribavirin. Interferon can be used alone but is then less effective (around 10%-20%). The antiviral drugs may cause significant side effects that may be intolerable for some people. These include:
headaches.
flu-like symptoms.
nausea.
tiredness.
body aches.
depression.
skin rashes.
The cost of this antiviral treatment is high, making it difficult to access in low-income and developing countries. A patient will also require regular check-ups to monitor their progress.
It is important to remember that if HCV treatment is effective and the infection is cleared, this does not mean the patient has future immunity to hepatitis C.

Follow-up

If a patient has been diagnosed with hepatitis C infection, they will be advised to have regular blood tests and physical check-ups.
The infected person should limit the amount of alcohol they drink as alcohol puts strain on the liver. The doctor may also advise avoiding fatty foods and following a low-salt diet.
Hepatitis A is the most common of the seven known types of viral hepatitis. Infection with the hepatitis A virus leads to inflammation of the liver, but complications are rarely serious.

How hepatitis A is spread

The hepatitis A virus (HAV) is found in the faeces of someone infected with the virus. It only takes a tiny amount of faeces getting inside another person’s mouth to cause hepatitis A infection. Personal hygiene, such as careful hand washing, can minimise the risk of the virus being passed on.
HAV is a common infection in many parts of the world where sanitation and sewage infrastructure is poor. Often people become infected with HAV by eating or drinking contaminated food or water.
Hepatitis A is also classed as a sexually transmitted disease (STD) because it can be passed on sexually, particularly during activities such as anilingus (rimming). The washing of genital and anal areas before sex, and the use of condoms or dental dams can help to prevent this risk.
Hepatitis A can affect all age groups. Once a person is exposed to the virus it takes between 2 and 6 weeks to produce symptoms.

Signs and symptoms of hepatitis A

It is possible to experience mild or no symptoms whatsoever, but even if this is the case the person’s faeces will still be infectious to others. Many people who become infected with HAV will have symptoms that include:

a short, mild, flu-like illness.
nausea, vomiting and diarrhoea.
loss of appetite.
weight loss.
jaundice (yellow skin and whites of eyes, darker yellow urine and pale faeces).
itchy skin.
abdominal pain.
The infection usually clears in up to 2 months, but may occasionally recur or persist longer in some people. Once a person has been infected and their body has fought off the virus they are permanently immune. Occasionally symptoms may be severe and require monitoring in hospital.
There are rarely any complications with hepatitis A infection. Permanent damage to the liver is very unlikely, but in extremely rare cases the infection can be fatal, particularly in older people.

Where to go for help

If you have any symptoms or you are worried you may have been infected with hepatitis A, you should discuss your worries with a doctor. They may be able to run tests themselves, or else will refer you to someone who can.
Some countries have specific sexual health clinics that can help you directly. Check our help and advice page or your local telephone directory to see if you have a clinic near you.

What does a positive test result mean?

HAV is tested for using a blood test. A positive test result means the patient has either had a past infection or is currently infected. The type of antibody detected in the test will indicate whether the infection is current or has been cleared. A patient who tests positive may be asked about recent contacts and sexual partners that may need to be tested too. A patient who has already had the infection and fought it off is naturally immune to HAV.

What does a negative test result mean?

A negative test result means the patient is not infected with Hepatitis A. If the patient is believed to be at high or ongoing risk of infection, a doctor may advise immunisation.

Treatment

There is no specific treatment for HAV and most people fight off the virus naturally, returning to full health within a couple of months. The doctor will advise avoiding alcohol and fatty foods as these can be hard for the liver to process and may exacerbate the inflammation.
Patients should get plenty of rest and eat a nutritious diet. They should also ensure they do not spread HAV by washing their hands after using the toilet and before preparing food. Patients with more severe symptoms may be monitored in hospital for a short period.

Immunisation

Hepatitis A immunisation is given in a series of injections. The first single injection in the arm gives protection for a year. The second booster injection at 6 to 12 months extends protection for up to 10 years.
The hepatitis A vaccine may be routinely recommended for young children living in areas with high incidence of hepatitis A, and anyone travelling to countries where hepatitis A is endemic. In addition, immunisation may be recommended for people whose sexual practices are likely to put them at risk.
Immunisation may also be recommended to prevent hepatitis A developing if a person suspects they have been exposed to the virus.

Follow-up

Someone who is infected with hepatitis A should limit the amount of alcohol they drink. Their doctor may also offer dietary advice.
The doctor will advise about any precautions necessary to avoid infecting others with the virus.


Hepatitis B is similar to hepatitis A in its symptoms, but is more likely to cause chronic long-term illness and permanent damage to the liver if not treated.

How hepatitis B is spread

The hepatitis B virus (HBV) is very common worldwide, with more than 350 million people infected. Those with long term HBV are at high risk of developing liver cirrhosis or liver cancer.
Hepatitis B is most frequently passed on through the exchange of bodily fluids with an infected person. HBV is estimated to be 50 to 100 times more infectious than HIV.
HBV can be spread in the following ways:
-by unprotected (without a condom) penetrative sex (when the penis enters the anus, vagina or mouth) with someone who is infectious. Also by sex that draws blood with someone who is infected.
-by sharing contaminated needles or other drug-injecting equipment.
-by using non-sterilised equipment for tattooing, acupuncture or body piercing.
-from an infected mother to her baby, most commonly during delivery. Immunisation of the baby at birth prevents the transmission of hepatitis B.
-through a blood transfusion in a country where blood is not screened for blood-borne viruses such as HBV.
Hepatitis B cannot be spread through sneezing, coughing, hugging or coming in contact with the faeces of someone who is infected.

Signs and symptoms of hepatitis B

Many people who become infected with HBV experience mild symptoms or no symptoms at all, but they may still carry the infectious virus and pass it on to others. When symptoms do appear they are similar to those of hepatitis A and may include:
-a short, mild, flu-like illness.
-nausea, vomiting and diarrhoea.
-loss of appetite.
-weight loss.
-jaundice (yellow skin and whites of eyes, darker yellow urine and pale faeces).
-itchy skin.
If symptoms become severe then a person with hepatitis B may be admitted to hospital.
Most adults infected with the hepatitis B virus fully recover and develop life-long immunity. Between 2% and 10% of individuals infected as adults will become chronic carriers, which means they will be infectious to others and can develop chronic liver damage. Infected children, especially newborn babies, are much more likely to become chronic carriers.
If a person lives with hepatitis B infection for a number of years then they may develop the following complications:
-chronic hepatitis.
-liver cirrhosis.
-liver cancer.

Where to go for help

If you have any symptoms or you are worried you may have been infected with hepatitis B, you should discuss your worries with a doctor. They may be able to run tests themselves, or else will refer you to someone who can.
Some countries have specific sexual health clinics that can help you directly. Check our help and advice page or your local telephone directory to see if you have a clinic near you.

What does a positive test result mean?

A positive test result could indicate either of the following:
-A past infection. This means the patient has already been in contact with hepatitis B and their immune system has succeeded in fighting off the virus. The patient will then have a natural immunity to the virus.
-The patient is a carrier. This means the patient is carrying HBV and can pass it on to others. The person may not display any symptoms but could be at risk of developing chronic liver disease.
A doctor may perform a number of different types of test to distinguish between current and past infections, and to estimate how infectious a patient with a current infection may be.

What does a negative test result mean?

This result generally means the patient has never been infected with HBV and therefore has no natural immunity against the virus. If the person suspects they may have been recently exposed to HBV, the doctor may advise them to take a repeat test to confirm their negative status, and may also advise immunisation against hepatitis B.

Treatment

In most countries a patient with a positive test result will be referred to a specialist who will carry out further tests to determine the degree to which hepatitis B may be affecting the liver, and what may be the best treatment options. In these tests a small sample of liver tissue may need to be taken (a liver biopsy).
In the majority of patients with active HBV, symptoms will not be severe and treatment will not be required. The patient will be monitored and after a few months the patient’s immune system should fight off the virus, giving the patient natural immunity.
In around 5% of adults, 30-50% of young children (aged 1-4), and 90% of infants, HBV infection will become chronic. The virus is more deadly to the young and those that are infected at birth have a 25% chance of developing a life-threatening liver-related illness.
Antiviral medication is given as treatment to those with chronic symptoms to help prevent further liver damage. These medications may be injected or given in pill form. Examples are Interferon Alpha, Lamivudine and Baraclude. Treatment usually lasts 6 months, during which the patient will be carefully monitored.
Regardless of whether the infection is producing symptoms or not, the patient will be advised to avoid alcohol, get plenty of rest and maintain a healthy diet.

Immunisation

Three immunisation injections are given over a period of 3-6 months. A blood test is taken once the course of injections is completed to check that they have worked. Immunity should last for at least 5 years.

Follow-up

A patient with an active infection will be advised to have regular blood tests and physical check-ups to monitor the virus, even if they are not receiving treatment. All carriers of HBV should expect to be referred to specialist services.
The doctor or nurse may advise the patient to avoid alcohol, fatty foods and follow a low-salt diet. They will also describe any precautions necessary to ensure that the patient avoids infecting others with the virus, such as not sharing toothbrushes or shaving equipment.
It is most important to use a condom for penetrative sex to prevent passing on the virus. Sexual partners of the patient should be tested and immunised against HBV (if not already infected).


tags:HEPATITIS,HEPATITIS A,b,c HEAPTITIS ,hepatitis c

Popular Posts